Literature DB >> 22825492

Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines.

Toshio Tsuyuguchi1, Harutoshi Sugiyama, Yuji Sakai, Takao Nishikawa, Osamu Yokosuka, Toshihiko Mayumi, Seiki Kiriyama, Masamichi Yokoe, Tadahiro Takada.   

Abstract

BACKGROUND/
PURPOSE: In 2007, the Tokyo Guidelines (TG07) working group established diagnostic criteria for assessment of the severity of acute cholangitis. This study aimed to analyze outcomes and identify predictors of mortality in patients with acute cholangitis managed according to the TG07.
METHODS: In this study, 215 consecutive cases of acute cholangitis were reviewed. Risk factors associated with mortality or refractory cholangitis, which is defined on the basis of prolonged hospitalization (>28 days) or disease resulting in fatality, were examined using multivariate logistic regression analysis.
RESULTS: There were 52, 133, and 30 cases of mild, moderate, and severe cholangitis, respectively. The overall mortality rate was 4.2 % (9/215). Mortality rates in patients with mild, moderate, and severe cholangitis were 0, 2.3, and 20.0 %, respectively (moderate vs. severe, p = 0.001). Multivariate analysis showed that serum albumin levels ≤2.8 g/dl and PT-INR >1.5 were significant predictors of mortality. There were 57 patients (26.5 %) with refractory cholangitis. Multivariate analysis showed that serum albumin level ≤2.8 g/dl, PT-INR >1.5, etiology and inpatient status were significant predictors of refractory cholangitis.
CONCLUSIONS: The TG07 severity assessment criteria for acute cholangitis were significantly predictive of mortality. Hypoalbuminemia is an important risk factor in addition to organ dysfunction.

Entities:  

Mesh:

Year:  2012        PMID: 22825492     DOI: 10.1007/s00534-012-0538-2

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  6 in total

1.  Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator.

Authors:  Susumu Tazuma; Yoshinori Igarashi; Kazuo Inui; Hirotaka Ohara; Toshio Tsuyuguchi; Shomei Ryozawa
Journal:  J Gastroenterol       Date:  2014-05-03       Impact factor: 7.527

2.  Should lactate be added to Tokyo criteria for the evaluation of patients with acute cholangitis?

Authors:  Erdinc Gulumsek; Fatih Yesildal; Ismail Yigitdol; İbrahim Erdem; Huseyin Can Arbag; Akkan Avci; Tayyibe Saler; Banu Kara; Adnan Tas; Hilmi Erdem Sumbul
Journal:  Ir J Med Sci       Date:  2022-02-08       Impact factor: 1.568

3.  Evaluation of Charcot Triad, Reynolds Pentad, and Tokyo Guidelines for Diagnosis of Cholangitis Secondary to Choledocholithiasis Across Patient Age Groups.

Authors:  Avesh J Thuluvath; Joseph C Ahn; Puru Rattan; Ahmed T Kurdi; Thoetchai B Peeraphatdit; Marielle J Kamath; Ryan J Lennon; John J Poterucha; Bret T Petersen; Patrick S Kamath
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-04-08

Review 4.  Cholangitis: Diagnosis, Treatment and Prognosis.

Authors:  Amir Houshang Mohammad Alizadeh
Journal:  J Clin Transl Hepatol       Date:  2017-09-07

5.  Worsening of Acute Cholangitis Caused by a Bile Duct Stone After Hospitalization: A Case Series.

Authors:  Tetsuro Akashi; Yuichi Tachibana; Susumu Matsuo; Junya Gibo
Journal:  Gastroenterology Res       Date:  2018-02-23

6.  Validation of TG07 and TG13/TG18 criteria for acute cholangitis and predictors of in-hospital mortality in patients over 80 years old.

Authors:  Ramkumar Mohan; Stefanie Wei Lynn Goh; GuanWei Tan; Sameer P Junnarkar; CheongWei Huey; Vishal G Shelat
Journal:  Clin Exp Hepatol       Date:  2021-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.